<DOC>
	<DOCNO>NCT01875354</DOCNO>
	<brief_summary>The purpose study assess safety efficacy weight management program compose dietary supplement reduce calorie eating program .</brief_summary>
	<brief_title>A Prospective Study Investigating Effects Novel Weight Management Program</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>1 . Male female 1865 year age time inform consent 2 . The ability read , speak understand English language order complete require paper inform consent , assessment diary 3 . Access email digital camera camera phone 4 . Willing able provide write informed consent 5 . Willing able comply study restriction , procedure assessment attend regularly schedule clinic visit 6 . Willing able accommodate contact study staff telephone call visit , followup contact , study visit reminder 7 . BMI equal great 25 less equal 40 kg/m2 8 . Use effective method contraception female childbearing potential 30days screen visit agree continue practice acceptable method contraception duration participation study 9 . A rest normotensive blood pressure , define systolic blood pressure 15090 mmHg diastolic blood pressure 9550 mmHg , screen visit 1 ( A ) 10 . Willing fast least 8 hour prior study procedure perform require fast measurement 11 . Willing able follow eat program able consume study supply Supplements , Placebos shake ( include whey and/or egg protein ) daily basis . Subjects lactose intolerant consider ineligible 12 . Only one member per household eligible participate study 1 . A subject Axis I Psychiatric disorder accord DSMIV criterion would prevent subject able comply study requirement and/or take antipsychotic medication 2 . Diagnosed insomnia chronically use prescribe OTC insomnia medication 3 . A selfreported chronic condition may affect subject safety 4 . An HbA1c great equal 7.0 % 5 . Renal insufficiency define laboratory Glomerular Filtration Rate le 50 mL/min/1.73 m2 6 . Chronically use glucocorticoid steroid 7 . Currently pregnant , plan become pregnant course study breastfeed 8 . Use antihypertensive medication ( ) less 90 day prior screen 9 . Diagnosed thyroid disorder clinically significant range laboratory value ( i.e . TSH , T3 Free , and/or T4 Free ) value measure screen 10 . Known allergy intolerance ingredient contain Novel Supplements , placebo shake ( cow milk protein ) 11 . Planned surgical procedure 365 day course study 12 . Currently participate another clinical research study do within 30 day prior screen visit 13 . Diagnosis milk egg intolerance 14 . Participating another weight loss program use another weight loss product . Subjects may enroll willing stop weight loss program currently and/or washout product use . The appropriate washout review investigator medically qualify designee case case basis 15 . Fasting LDLC great 190 mg/dL triglyceride great 400 mg/dL . 16 . Unwilling discontinue consumption green black tea green black tea extract begin screen visit signing inform consent 17 . Unwilling discontinue use overthecounter and/or prescribe vitamin supplement except : multivitamin , calcium , fish oil , vitamin C , vitamin D , vitamin E , zinc iron 18 . Plans plastic reconstructive surgery procedure , opinion investigator , could influence body composition , time year long study 19 . Unable lay supine least 30 minute 20 . Cognitive impairment would limit ability understand follow diet instruction and/or comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>